HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylvain Perruche Selected Research

Vasculitis (Vasculitides)

5/2016[Proteinase 3: a new danger signal and a double agent in vasculitis].
11/2015Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylvain Perruche Research Topics

Disease

7Inflammation (Inflammations)
01/2021 - 01/2007
6Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 01/2003
5Autoimmune Diseases (Autoimmune Disease)
01/2021 - 08/2003
4Rheumatoid Arthritis
01/2021 - 11/2016
4Arthritis (Polyarthritis)
01/2021 - 01/2009
2Neoplasms (Cancer)
01/2021 - 12/2016
2Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 10/2010
2Experimental Arthritis
01/2019 - 11/2016
2Vasculitis (Vasculitides)
05/2016 - 11/2015
1Wounds and Injuries (Trauma)
01/2021
1Colitis
01/2021
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
11/2015
1Hematologic Diseases (Blood Diseases)
10/2010
1Hypersensitivity (Allergy)
07/2009
1Necrosis
11/2008
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2008
1HIV Infections (HIV Infection)
01/2007
1Colonic Neoplasms (Colon Cancer)
01/2007
1Bronchiolitis Obliterans Syndrome
02/2006

Drug/Important Bio-Agent (IBA)

3Therapeutic UsesIBA
01/2021 - 05/2008
3Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 11/2016
2Myeloblastin (Proteinase 3)IBA
05/2016 - 11/2015
2CytokinesIBA
01/2009 - 11/2008
1LipoxinsIBA
01/2021
1Fibronectins (Fibronectin)IBA
01/2021
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2021
1Synthetic DrugsIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1LipidsIBA
01/2021
1ProstaglandinsIBA
01/2021
1Biological ProductsIBA
01/2021
1LeukotrienesIBA
01/2021
1Dextrans (Dextran)FDA Link
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1Collagen Type II (Type II Collagen)IBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1CholesterolIBA
12/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2016
1PerforinIBA
01/2016
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2015
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
06/2015
1Interferon-alpha (Interferon Alfa)IBA
01/2012
1Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2009
1InterleukinsIBA
11/2008
1GlucocorticoidsIBA
11/2008
1CTLA-4 AntigenIBA
11/2008
1AntibodiesIBA
11/2008
1Myelin-Oligodendrocyte GlycoproteinIBA
05/2008
1Transforming Growth Factor beta (TGF-beta)IBA
01/2007
1AutoantibodiesIBA
02/2006
1AutoantigensIBA
08/2003
1LF 150195IBA
01/2003
1gusperimusIBA
01/2003

Therapy/Procedure

5Therapeutics
01/2021 - 01/2009
4Cell Transplantation
01/2021 - 10/2010
3Transplantation
01/2017 - 10/2013
1Surgical Instruments (Clip)
01/2021
1Subcutaneous Injections
01/2019
1Photopheresis
01/2019